Impact of morning symptoms in clinical control of Chronic Obstructive Pulmonary Disease (COPD) - IMPAEPOC

Study identifier:NIS-RES-DUM-2010/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Impact of morning symptoms in clinical control of COPD

Medical condition

COPD

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

1268

Study type

Observational

Age

40 Years +

Date

Study Start Date: 01 Jan 2010

Primary Completion Date: -

Study Completion Date: 01 Jul 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2011 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Spain Clinical Study Information

[email protected]